CH BIOTECH SER (08037) announced that on March 30, 2026, following the recommendation of the company's remuneration committee, the board of directors resolved to grant a total of 4.5 million incentive shares at zero cost to seven selected participants under the share incentive plan. These shares represent approximately 0.46% of the total issued shares as of the announcement date. The grant is conditional upon acceptance by the recipients. The 4.5 million incentive shares were acquired by the trustee from the open market using the company's internal resources provided to the trustee. Based on the closing price of HK$0.81 per share on the grant date, the market value of the 4.5 million incentive shares is HK$3.645 million.